IP6K1 protein levels are increased in obesity[49], and patients with nonalcoholic fatty liver disease[39], which is associated with reduced plasma levels of apoA-I and HDL[50]. Here, APOA1 is linked to metabolic dysfunction-associated steatotic liver disease.